CNET [ChinaNet Onlines,] SC TO-I/A: SCHEDULE TO Description (a)(5)(B) Press Releaseted December 1,

[SCHEDULE TO Description (a)(5)(B) Press Releaseted December 1, 2011 (a)(5)(C) 1 After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,mplete andrrect. CHINANET ONLINES, 2 Description (a)(5)(B) Press Releaseted December 1, 2011] [The Offer willntinue for a period of twenty (20) businessys from thete of this release and will expire on December 30, 2011, at 5:00 p.m., Eastern Time, or for suchditional time is required under applicable law. yasminewei@chinanet-online.com The foregoing reference to the offer and any other related transactions shall notnstitute an offer to buy or] [December 7, 2011 We are writing this letter to thank you for your support of ourmpany over the past two years. We believe that ChinaNet is ampany transformed for the better. We have moved from a simple internetvertisingmpany into a true internet-based services and technologympany. We have a growing client base and are offering upgraded]

By | 2016-02-08T11:44:38+00:00 December 7th, 2011|Categories: Chinese Stocks, CNET, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC TO-I/A: (Original Filing)

[_____________ SCHEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) _____________ CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 _____________________ ) _____________ Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong] [HONG KONG, China, December 13, - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “We believe shareholders will appreciate our simplified capital structure. With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis. With all the stakeholders’ interests now]

By | 2016-02-29T15:45:48+00:00 December 13th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC TO-I/A: _____________ SCHEDULE TO (Amendment No. 2) _____________ (Rule

[_____________ SCHEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) _____________ CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 _____________________ ) _____________ Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong] [HONG KONG, China, December 13, - China Cord Blood Corporation Ms. Ting Zheng, Chairperson and CEO of China Cord Blood Corporation commented, “We believe shareholders will appreciate our simplified capital structure. With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis. With all the stakeholders’ interests now]

By | 2016-02-29T15:47:01+00:00 December 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC TO-I/A: (Original Filing)

[_____________HEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) _____________ CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 _____________________ ) _____________bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower] [HONG KONG, China, December 13, - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, We believe shareholders will appreciate our simplifiedpital structure.With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis.Withl the stakeholders interests now fullyigned, we willntinue to]

By | 2016-02-04T18:01:49+00:00 December 13th, 2010|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC TO-I/A: _____________HEDULE TO (Amendment No. 2) _____________ (Rule 14d-100)

[_____________HEDULE TO (Amendment No. 2) _____________ (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) _____________ CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 _____________________ ) _____________bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower] [HONG KONG, China, December 13, - Chinard Bloodrporation Ms. Ting Zheng, Chairperson and CEO of Chinard Bloodrporationmmented, We believe shareholders will appreciate our simplifiedpital structure.With no further dilution, shareholders will fully enjoy the benefits of our operational accomplishments and robust growth, even on a per share basis.Withl the stakeholders interests now fullyigned, we willntinue to]

By | 2016-02-04T18:02:43+00:00 December 13th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC TO-I/A: SCHEDULE TO (Amendment No. 1) (Rule 14d-100) Tender

[SCHEDULE TO (Amendment No. 1) (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) CHINA CORD BLOOD CORPORATION (Name of Subject Company (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities) KYG211071181 ) Albert Chen +852 3605 8180 albert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. (Name, Address and Telephone]

By | 2016-02-29T15:54:52+00:00 November 19th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [Chinard Bloodrp] SC TO-I/A: SCHEDULE TO (Amendment No. 1) (Rule 14d-100) Tender

[SCHEDULE TO (Amendment No. 1) (Rule 14d-100) Tender Offer Statement under Section14(d)(1) or 13(e)(1) CHINARD BLOODRPORATION (Name of Subjectmpany (Issuer) and Name of Filing Person (Issuer)) (Title of Class of Securities)G211071181 )bert Chen +852 3605 8180bert.chen@chinacordbloodcorp.com 48th Floor, Bank of China Tower 1 Garden Road]

By | 2016-02-04T18:08:14+00:00 November 19th, 2010|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CCCL [China Ceramics] SC TO-I/A: (Original Filing)

[] [China Ceramics Co., Ltd. Jinjiang, Fujian Province, China, September 1, 2010 – This news release is merely a notification of the results of the Offer and is neither an offer to buy or exchange securities and does not constitute the solicitation of an offer to sell or exchange any securities in the Company or any of its subsidiaries. The Offer]

By | 2016-03-21T20:20:10+00:00 September 1st, 2010|Categories: CCCL, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar